Upstream Partners

News

Upstream News

Posts tagged IP Licensing
Daily Distillery Introduces Vodkow
“Vodkow Bottle".”  Vodkow

“Vodkow Bottle".” Vodkow

Vodkow – vodka from a cow

The Dairy Distillery, in Almonte, Ontario, has brought together artisanal distilling techniques with cutting edge science to develop Vodkow, vodka made from cow’s milk. 

Omid McDonald, founder of Dairy Distillery, learned about unwanted milk permeate – the leftover from milk after the fats and proteins are taken out to make popular dairy products such as ice cream, cheese and butter, and worked with the University of Ottawa to find a yeast that can consume lactose and produce alcohol.

McDonald hopes that “more people will start making use of this lactose, which is currently being wasted. So we will see it as a positive thing if other people also started working with milk-based spirits.”

Click here to read more about Dairy Distillery.

 

New Wave Endo
“New Wave Endo".”  Upstream Partners

“New Wave Endo".” Upstream Partners

New Wave Endo announces M-Close surgical device

New Wave Endo announced the launch of the M-Close surgical device at the American College of Surgeons Clinical Congress on October 22, 2018. The M-Close multifunction closure device combines targeted anesthesia delivery with the most advanced port closure device for laparoscopic surgery. As of the date of this article, the device is not yet available for sale in the U.S.

The M-Close was conceived of and developed by the late Dr. Manoj B. Patel, a dear friend and colleague of Upstream Partners.

New Wave Endo is run by the same team that founded and ran New Wave Surgical, which was acquired by Covidien in 2014. Read more about the acquisition here.

Children's Hospital spinoff

Upstream assists Children's National Medical Center in Robotic Surgery venture

Upstream Partners helped negotiate a license and structure a transaction that provided Omniboros, Inc., a robotic surgery company spun out of Children's National Health System, with a license to a large patent portfolio and additional know-how. Omniboros raised $1.5 million in funding from Great Point Ventures, a Silicon Valley-based venture capital firm.

The technology, known as the Smart Tissue Autonomous Robot, or STAR, has demonstrated the ability to conduct autonomous soft tissue surgery with a robotic device. The device has demonstrated the ability to suture live pigs and inanimate pig tissue with more precision than a human hand. Omniboros, based in Washington, DC., will continue in vivo testing throughout 2017 and 2018.

Click here to view the article.

Glaukos stent for glaucoma treatment

Tiny New Device Helping Glaucoma Patients

A revolutionary new treatment for glaucoma is helping patients keep their eyesight. The Glaukos iStent, the smallest medical device approved by the FDA, is a one millimeter titanium tube that is put in the drainage channel in the eye to reduce pressure build-up and keep eye fluid flowing. Until the approval of the iStent, eye drops and laser surgery were the only treatment options, which come with problems. each of which has limitations, with repeat surgery often needed .

Upstream helped with negotiations related to a license between the physician inventor of the stent to Glaukos.

Click here to view the article.